HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Reactive airway disease — Clinical Guidelines

Overview

Reactive airway disease encompasses conditions characterized by airway inflammation and hyperresponsiveness, often manifesting as asthma or chronic obstructive pulmonary disease (COPD). These conditions are marked by symptoms such as wheezing, shortness of breath, and mucus production, influenced by factors like vitamin D deficiency and type 2 inflammation 1 7.

Diagnosis

Clinical Symptoms: Wheezing, shortness of breath, cough, and sputum production.

Lung Function Tests: Spirometry to assess airflow obstruction and reversibility.

Imaging: High-quality MRI can be an alternative to CT for evaluating pediatric large airways 6.

Bronchoscopy: Useful for visualizing airway pathology and obtaining biopsies 10 17.

Exhaled Nitric Oxide (FeNO): Measures airway inflammation, though methodological factors must be considered in infants 18.

Management

First-Line Treatments:

- Inhaled Corticosteroids: Reduce airway inflammation. - Long-Acting Beta-Agonists (LABAs): Provide bronchodilation. - Type 2 Monoclonal Antibodies: Effective in reducing exacerbations and improving lung function in eosinophil-associated chronic airway diseases 2.

Adjunctive Treatments:

- Probiotics: Potential supplementary therapy for allergic airway diseases in children, though efficacy is still under investigation 3. - Vitamin D Supplementation: Addressing deficiency may mitigate exacerbation risk 1. - Environmental Control Measures: Reducing exposure to allergens and irritants 7.

Special Populations

Pediatrics:

- Flexible Bronchoscopy: Often performed under sedation with propofol for safety 16 24. - Non-Invasive Positive-Pressure Ventilation (NPPV): Considered for severe obstructive conditions 12.

Elderly: Diagnostic accuracy of clinical symptoms varies; lung function tests are crucial 14.

Comorbidities: Management should consider interactions, such as theophylline levels in patients with obstructive airway disease 23.

Key Recommendations

Monitor and Address Vitamin D Levels: Regular assessment and supplementation if deficient to reduce exacerbation risk (Evidence: Moderate 1).

Utilize Type 2 Monoclonal Antibodies: Consider in patients with eosinophil-associated chronic airway diseases for improved outcomes (Evidence: Strong 2).

Implement Environmental Controls: Educate patients and caregivers on reducing allergen exposure to manage allergic airway diseases (Evidence: Expert opinion 7).

Lung Function Testing: Essential for accurate diagnosis and monitoring of obstructive airway diseases across healthcare sectors (Evidence: Moderate 14).

Sedation Protocols for Pediatric Bronchoscopy: Use propofol for safe and effective sedation in children (Evidence: Moderate 16 24).

References

1 Stapleton EM, Thurman AL, Pezzulo AA, Comellas AP, Thornell IM. Increased ENaC-mediated liquid absorption across vitamin-D deficient human airway epithelia. American journal of physiology. Cell physiology 2024. link 2 Wu Y, Huang M, Zhong J, Lu Y, Gan K, Yang R et al.. The clinical efficacy of type 2 monoclonal antibodies in eosinophil-associated chronic airway diseases: a meta-analysis. Frontiers in immunology 2023. link 3 Chen N, Liu F, Gao Q, Wang R, Zhang L, Li Y. A Meta-Analysis of Probiotics for the Treatment of Allergic Airway Diseases in Children and Adolescents. American journal of rhinology & allergy 2022. link 4 Wang JT, Peyton J, Hernandez MR. Anesthesia for pediatric rigid bronchoscopy and related airway surgery: Tips and tricks. Paediatric anaesthesia 2022. link 5 Kalsi HS, Thakrar R, Gosling AF, Shaefi S, Navani N. Interventional Pulmonology: A Brave New World. Thoracic surgery clinics 2020. link 6 Liszewski MC, Ciet P, Sodhi KS, Lee EY. Updates on MRI Evaluation of Pediatric Large Airways. AJR. American journal of roentgenology 2017. link 7 Paramesh H, Nagaraju K, Sukumaran TU, Agarkhedkar S, Bhakta S, Tilak R et al.. Airway Diseases Education and Expertise (ADEX ) in Pediatrics: Adaptation for Clinical Practice in India. Indian pediatrics 2016. link 8 Kumar A, Raju S, Das A, Mehta AC. Vessels of the Central Airways: A Bronchoscopic Perspective. Chest 2016. link 9 Gilbert CR, Feller-Kopman D, Akulian J, Hayes M, Yarmus L. Interventional pulmonology procedures in the pediatric population. Pediatric pulmonology 2014. link 10 Obusez EC, Jamjoom L, Kirsch J, Gildea T, Mohammed TL. Computed tomography correlation of airway disease with bronchoscopy: part I--nonneoplastic large airway diseases. Current problems in diagnostic radiology 2014. link 11 Duncavage J, Hagaman DD. Practical aspects of integrating allergy and pulmonology management into a rhinology practice: the Vanderbilt ASAP experience. Current opinion in otolaryngology & head and neck surgery 2013. link 12 Leboulanger N, Fauroux B. Non-invasive positive-pressure ventilation in children in otolaryngology. European annals of otorhinolaryngology, head and neck diseases 2013. link 13 Buffels J, Degryse J, Liistro G, Decramer M. Differential diagnosis in a primary care population with presumed airway obstruction: a real-life study. Respiration; international review of thoracic diseases 2012. link 14 Schneider A, Ay M, Faderl B, Linde K, Wagenpfeil S. Diagnostic accuracy of clinical symptoms in obstructive airway diseases varied within different health care sectors. Journal of clinical epidemiology 2012. link 15 Onakpoya UU, Adewole O, Ogunrombi AB, Adenekan AT. Oxygen supplementation during awake fibreoptic bronchoscopy in a Nigerian tertiary hospital. West African journal of medicine 2012. link 16 Hasan RA, Reddy R. Sedation with propofol for flexible bronchoscopy in children. Pediatric pulmonology 2009. link 17 Deutsch ES, Christenson T, Curry J, Hossain J, Zur K, Jacobs I. Multimodality education for airway endoscopy skill development. The Annals of otology, rhinology, and laryngology 2009. link 18 Gabriele C, van der Wiel EC, Nieuwhof EM, Moll HA, Merkus PJ, de Jongste JC. Methodological aspects of exhaled nitric oxide measurements in infants. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2007. link 19 Castellanos P. The laryngology hospitalist. Journal of voice : official journal of the Voice Foundation 2005. link 20 Tobias JD. Sedation and anesthesia for pediatric bronchoscopy. Current opinion in pediatrics 1997. link 21 Hadnagy W, Stiller-Winkler R, Idel H. Immunological alterations in sera of persons living in areas with different air pollution. Toxicology letters 1996. link03730-7) 22 Berry FA, Yemen TA. Pediatric airway in health and disease. Pediatric clinics of North America 1994. link38697-7) 23 Barr JT, Schumacher GE, Luks DB, Karpel J. Mild theophylline-related adverse reactions and serum theophylline concentration. American journal of hospital pharmacy 1994. link 24 Raine J, Warner JO. Fibreoptic bronchoscopy without general anaesthetic. Archives of disease in childhood 1991. link

Reactive airway disease